Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Significant Are Moderna's Asian Regulatory Wins?


Moderna (NASDAQ: MRNA) recently went two for two in Asia. The company picked up an approval in Japan for its COVID-19 vaccine and secured authorization in South Korea. In this Motley Fool Live video, recorded on May 26, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the impact of these regulatory wins for Moderna.

Continue reading


Source Fool.com

Like: 0
Share

Comments